Ratiometric electrochemical detection of kojic acid based on glassy carbon modified MXene nanocomposite.

The significance of developing a selective and sensitive sensor for quality control purposes is underscored by the prevalent use of kojic acid (KA) in cosmetics, pharmaceuticals, and food items. KA's utility stems from its ability to inhibit tyrosinase activity. However, the instability of KA and its potential adverse effects have created a pressing need for accurate and sensitive sensors capable of analyzing real samples. This research introduces an electrochemical ratiometric sensor designed to accurately detect KA in actual cosmetic and food samples. The ratiometric sensor offers distinct advantages such as enhanced selectivity, reproducibility, and sensitivity. It achieves this by leveraging the ratio between two output signals, thereby producing reliable and undistorted results. The sensor is constructed by modifying a Glassy Carbon Electrode (GCE) with a nanocomposite consisting of Ti3C2 MXene, Prussian blue, and gold nanoparticles. The incorporation of MXene and gold nanoparticles heightens sensitivity and reduces impedance. Meanwhile, the Prussian blue signal diminishes proportionally with increasing KA concentration, forming the basis for the ratiometric sensing mechanism. The outcomes of the study reveal a broad linear range (1-600 µM), a low detection limit (1 µM), and strong selectivity for KA. These findings suggest the sensor's potential efficacy in quality control across cosmetics, pharmaceuticals, and food products.

Electrochemical sensors for cortisol detection: Principles, designs, fabrication, and characterisation.

Psychological stress is a major factor contributing to health discrepancies among individuals. Sustained exposure to stress triggers signalling pathways in the brain, which leading to the release of stress hormones in the body. Cortisol, a steroid hormone, is a significant biomarker for stress management due to its responsibility in the body's reply to stress. The release of cortisol in bloodstream prepares the body for a "fight or flight" response by increasing heart rate, blood pressure, metabolism, and suppressing the immune system. Detecting cortisol in biological samples is crucial for understanding its role in stress and personalized healthcare. Traditional techniques for cortisol detection have limitations, prompting researchers to explore alternative strategies. Electrochemical sensing has emerged as a reliable method for point-of-care (POC) cortisol detection. This review focuses on the progress made in electrochemical sensors for cortisol detection, covering their design, principle, and electroanalytical methodologies. The analytical performance of these sensors is also analysed and summarized. Despite significant advancements, the development of electrochemical cortisol sensors faces challenges such as biofouling, sample preparation, sensitivity, flexibility, stability, and recognition layer performance. Therefore, the need to develop more sensitive electrodes and materials is emphasized. Finally, we discussed the potential strategies for electrode design and provides examples of sensing approaches. Moreover, the encounters of translating research into real world applications are addressed.

Emerging trends in point-of-care biosensing strategies for molecular architectures and antibodies of SARS-CoV-2.

COVID-19, a highly contagious viral infection caused by the occurrence of severe acute respiratory syndrome coronavirus (SARS-CoV-2), has turned out to be a viral pandemic then ravaged many countries worldwide. In the recent years, point-of-care (POC) biosensors combined with state-of-the-art bioreceptors, and transducing systems enabled the development of novel diagnostic tools for rapid and reliable detection of biomarkers associated with SARS-CoV-2. The present review thoroughly summarises and discusses various biosensing strategies developed for probing SARS-CoV-2 molecular architectures (viral genome, S Protein, M protein, E protein, N protein and non-structural proteins) and antibodies as a potential diagnostic tool for COVID-19. This review discusses the various structural components of SARS-CoV-2, their binding regions and the bioreceptors used for recognizing the structural components. The various types of clinical specimens investigated for rapid and POC detection of SARS-CoV-2 is also highlighted. The importance of nanotechnology and artificial intelligence (AI) approaches in improving the biosensor performance for real-time and reagent-free monitoring the biomarkers of SARS-CoV-2 is also summarized. This review also encompasses existing practical challenges and prospects for developing new POC biosensors for clinical monitoring of COVID-19.

Towards the development of reagent-free and reusable electrochemical aptamer-based cortisol sensor.

Continuous monitoring of stress through detecting specific biochemical markers such as cortisol plays a crucial role in the early detection of various diseases. Electrochemical aptamer sensor involving binding induced conformational change allows the continuous measurement of biomarkers. A reagent-less aptamer-based biosensing platform that allows a continuous and real-time cortisol measurement is developed in this context. The aptamer is conjugated with methylene blue, which acts as a redox reporter to probe the cortisol binding quantitatively on the sensor surface. The cortisol specific aptamers were chemically modified with amine and thiol functional groups to facilitate redox reporter conjugation and attachment of aptamer to a gold electrode, respectively. The sensor achieves a clinically meaningful cortisol concentration ranging from 0.05 ng/mL to 100 ng/mL and provides good selectivity when challenged with structurally similar targets. The reagent-less measurement capability was also demonstrated using an undiluted human serum. The newly developed cortisol sensor can enable the systemic cortisol measurement for providing insights into cortisol related clinical conditions and medical treatments.